UNC Enrolling Volunteers in Three HIV Prevention Studies

As a major center for HIV research, UNC is now a site for three important studies testing a new pill, a long-acting injection and an infusion of antibodies to prevent HIV. The UNC Global HIV Prevention and Treatment Clinical Trials Unit is currently looking for men and transgender individuals who have sex with men. Study staff will screen volunteers to see if they are eligible to enroll in one of our HIV prevention studies.

Despite years of public health messaging about ways to reduce the risk of HIV, there are still approximately 50,000 new infections each year in the United States. For a variety of reasons, young people and men who have sex with men (especially in communities of color) are disproportionately impacted. Over the past several years, a number of new options for HIV prevention have rolled out – the most important of which is called pre-exposure prophylaxis, or PrEP. The idea behind PrEP is simple: taking anti-HIV medications before an exposure can successfully keep uninfected people from acquiring HIV through sex or injection drug use with a known or as yet undiagnosed HIV positive partner. As a major center for HIV research, UNC is now a site for three important studies testing a new pill, a long-acting injection and an infusion of antibodies to prevent HIV.

 

To learn more about UNC’s HIV prevention studies, please visit: http://www.med.unc.edu/ncaidstraining/prevention-studies or call 1-877-643-9040.